IP Library Granted Patent US 7,378,273
Granted Patent B2
US 7,378,273 · App. 10/947,881 · Granted May 27, 2008

Expression vectors

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,378,273
App. No.
10/947,881
Granted
May 27, 2008
Kind
B2
Abstract

The present invention provides novel regulatory elements and vectors for the expression of one or more proteins in a host cell. The present invention also provides methods for expressing one or more proteins, such as antibodies, in a host cell. These methods utilize the novel regulatory elements and vectors of the present invention for the expression of proteins in a host cell. The host cells are used for producing various protein products, including but not limited to pharmaceutical proteins, antibodies, variants of proteins for use in screening assays, and for direct use in high throughput screening.

Claims (4)

1. A vector comprising a nucleic acid sequence selected from the group consisting of SEQ ID NO:2 and variants of SEQ ID NO:2, wherein said variants are identical to SEQ ID NO:2 with the exception that positions 4, 112, and 238 of said variant of SEQ ID NO:2 are not guanine, and wherein said nucleic acid sequence facilitates high levels of expression of proteins without the need for incorporating introns into nucleic acids encoding said proteins.

2. The vector of claim 1 , wherein said vector is a retroviral vector.

3. An isolated host cell comprising the vector of claim 1 .

4. The vector of claim 1 , wherein said vector comprises multiple copies of said nucleic acid sequence.

Assignments (9)
RELEASE OF SECURITY INTEREST IN PATENT COLLATERAL (019323/0302) Recorded Dec 19, 2024
From: JPMORGAN CHASE BANK, N.A.
To: CATALENT PHARMA SOLUTIONS, LLC; R.P. SCHERER TECHNOLOGIES, INC.; R.P. SCHERER TECHNOLOGIES, LLC; R.P. SCHERER CORPORATION
Reel/Frame 069750/0933 →
NOTICE OF SUCCESSION OF AGENCY Recorded May 17, 2019
From: MORGAN STANLEY SENIOR FUNDING, INC.
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 049217/0981 →
MERGER Recorded Nov 9, 2010
From: GALA DESIGN, INC.
To: CARDINAL HEALTH PTS, LLC
Reel/Frame 025335/0780 →
CHANGE OF NAME Recorded Nov 9, 2010
From: CARDINAL HEALTH PTS, LLC
To: CATALENT PHARMA SOLUTIONS, LLC
Reel/Frame 025335/0827 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 9, 2010
From: BLECK, GREGORY T.
To: GALA DESIGN, INC.
Reel/Frame 025333/0929 →
CHANGE OF NAME Recorded Apr 30, 2008
From: R. P. SCHERER CORPORATION (A DELAWARE CORPORATION)
To: CARDINAL HEALTH 409, INC. (A DELAWARE CORPORATION)
Reel/Frame 020878/0188 →
CHANGE OF NAME Recorded Apr 30, 2008
From: CARDINAL HEALTH 409, INC. (A DELAWARE CORPORATION)
To: CATALENT PHARMA SOLUTIONS, INC. (A DELAWARE CORPORATION)
Reel/Frame 020878/0192 →
CHANGE OF NAME Recorded Jul 24, 2007
From: CARDINAL HEALTH 400, INC.; CARDINAL HEALTH 406, LLC; CARDINAL HEALTH 409, INC.; CARDINAL HEALTH 421, INC.; CARDINAL HEALTH PTS, LLC
To: CATALENT USA WOODSTOCK, INC.; CATALENT USA PACKAGING, LLC; CATALENT PHARMA SOLUTIONS, INC.; CATALENT USA PAINTBALL, INC.; CATALENT PHARMA SOLUTIONS, LLC
Reel/Frame 019588/0622 →
SECURITY AGREEMENT Recorded May 22, 2007
From: PTS ACQUISITION CORP.; PTS INTERMEDIATE HOLDINGS LLC; CARDINAL HEALTH 400, INC.; CARDINAL HEALTH 406, LLC; CARDINAL HEALTH 421, INC.; CARDINAL HEALTH PTS, LLC; R.P. SCHERER TECHNOLOGIES, INC.; GLACIER CORPORATION; CARDINAL HEALTH 409, INC.
To: MORGAN STANLEY SENIOR FUNDING, INC.
Reel/Frame 019323/0302 →